Study identifies G?13 as a key tumor suppressor in ER+ breast cancer

[News]

In looking for new ways to fight breast cancer, scientists from Duke-NUS Medical School have unmasked a surprising role of a protein generally associated with cancer growth. They have discovered that in estrogen receptor-positive (ER+) breast cancer, this protein acts as a tumor suppressor instead. ER+ breast cancer constitutes about 80 percent of all breast cancer diagnoses, yet nearly 50 percent of women diagnosed with it experience a relapse after initial treatment.

More... (https://www.news-medical.net/news/20240827/Study-identifies-Gceb113-as-a-key-tumor-suppressor-in-ER2b-breast-cancer.aspx)